Glanum Innovation IVS: Financial statements 2017
CVR: 37682837
Source: annual report 2017, Danish Business Authority
01/01/2017 – 31/12/2017
Glanum Innovation IVS (CVR 37682837) has filed annual accounts for 2017. In 2017, the company reported revenue of DKK 55,351 and a net result of DKK 3,120. The profit margin was 5.6%. Equity in the 2017 report amounted to DKK 37,569. The solvency ratio was 100%.
- Revenue
- DKK 55,351
- Gross Profit
- DKK 4,000
- Profit/Loss
- DKK 3,120
- Equity
- DKK 37,569
- Total Assets
- DKK 37,569
Official annual report
Keep an eye on Glanum Innovation IVS
Get notified instantly about new financial statements, ownership changes, management changes and status changes.
Set up monitoringEvents in 2017
Glanum Innovation IVS has published its interim report for the period May 13, 2016 to December 31, 2016.
About Glanum Innovation IVS
Glanum Innovation IVS was a Danish company of the type Iværksætterselskab based in Værløse, founded in 2016. The company has been dissolved on 4 February 2020. The company was registered under the industry Forskning og eksperimentel udvikling indenfor bioteknologi. In 2019, the company reported a gross profit of DKK 7,583 and a net result of DKK 7,583 compared with DKK 4,877 the year before. Equity in the 2019 report amounted to DKK 7,162.